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Low-level Biological Dosimetry of
Heterocyclic Amine Carcinogens Isolated
from Cooked Food
by Kenneth W. Turteltaub,' John S. Vogel,2 Chris
Frantz,' Michael H. Buonarati,' and James S. Felton'
The bioavailability and the bioreactivity ofthe carcinogenic heterocyclic amine [2-'4CJ2-amino-1-methyl-6phenyl-
inidazo[4,5-blpyridine(PhIP)havebeeninvestigteddadosea in thatlikluy fromthehumandietbyaccelerator
mass spectrometry (AMS). [2-_4CJPhIP musadministeredtomiceat a doseequivalent totheconsumption oftwo 100g
beefpatties(41 ng/kg). Thebiological halflifeofPhIPwas 1 hr, with90%ofthedosebeingexcreted viatheurine. Peak
tissuePhEPconcentrationswerereachedwithin3hr,withthehighestlevelsinthetissuesofthegastrointestiltract,follow-
edby theliver, kidney, pancreas, andthymus. SincethedetectionlimitbyAMSisdependent onthe natural abundance
of14C, wehaveachievedfurtherincreasesinsensitivitybyproducingmicethathave20%ofthenaturlabundanceof14C.
Useofthese 14C-depleted aniS all Ms rementStobemadenearthenaturallvelofexoreformanyenvironmen-
talcarcinogens. PhIP-DNAadductlevelshavealsobeenmeasuredby 32P-postlabeling atdosesof1.0 , and20mg/kg.
Thehighestadductlevelswerefound inthepancreas,thynms, heart, and iverandincreasedlinearly withdose. Theprin-
cipal adducts are derived from guanine.
Introduction
Determining the cancerriskthatchemicals posetohumanshas
proven tobe adifficulttask. Biomarkersplay anintegral rolein
this processbecause theoretically they indicate progress in the
developmentofdisease, butthebiomarkers mustbe selected to
validly representthediseasemechanism (1). Fundamentally at
issue is the relationship between the delivered dose and the in-
nateability ofanorganism, both on asystemicandcellularlevel,
to cope with the challenge. In a practical sense, translating the
carcinogenic response from high-dose animal studies to low-
dose human exposure scenarios istheimmediate concern from
thestandpointofa)developing validbiomarkersofexposureand
effect, b) for understanding mechanisms, and c) for risk
assessment.
HeterocyclicAminesinthe Dietandthe
Need for Low-level Dosimetry
Nowhere isthis riskevaluationproblem more acutethan in ac-
cessing thedosimetryofthegenotoxicdietaryheterocyclicamine
carcinogens formed during the cooking of meat [discussed in
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detailby FeltonandKnize(2)]. Dailyhumanexposuresforthese
compounds are probably on the order of a few nanograms/
kilogramofbodyweight(assuming anaverage70kgadultcon-
sumes200gofmeat/day), whiletheanimalbioassayshavebeen
carried outatdoses ofmg/kg (3). Likewise, pharmacokinetic,
metabolic, andmacromolecular adductmeasurements haveall
been made at doses in excess of 104- to 106-fold greater than
human dietary exposure levels. To determine the feasibility of
biomonitoringandforselectingappropriatebiologicalexposure
markers for use at human exposure levels, it is necessary to
understand thepharmacokinetics, metabolism, anddosimetry of
thesecarcinogensatrelevantdietarylevelsandtoreconcilethese
results to the high-dose studies at which bioassays have been
traditionally carried out.
Ourapproach tothisproblemhasbeen to focuson the DNA
adductas apotentialbiomarkerforbothexposureandeffect, and
we are using the high sensitivity offered by accelerator mass
spectromery (AMS) for assessing adduct dosimetric relation-
ships. AMSis alow-energynuclearphysicstechniquedeveloped
formeasuringcosmogenic isotopes such as 14C and is ideal for
studying the low-level dosimetry ofisotopically labeled xeno-
biotics(4,5). AMSisolatesandcountsspecificnucleiasopposed
tomeasuringatomicdecay. Thus, AMSmethodology results in
a 106-foldimprovementinisotopedetectionefficiencycompared
to scintillation counting for 'C and has allowed us to quan-
titatively measure DNA adduct levels on the order of 10 -1I to
10-12 adducts/nucleotide (6). We also have applied the 32p_
postlabeling assay to mechanistic studies oftheeffects ofthese
carcinogensonDNA. Thepostlabelingassayisahighlysensitive1TURTELTAUB ETAL.
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FIGURE 1. Percent ofthe administered dose of2-amino-l-methyl-6phenyl-
imidazo[4,5-blpyridine(PhIP foundintheurine(O), feces(-),andblood
(0) after administration of 1.25 ng/mouse. Means are from three ani-
mals/timepoint ± SE.
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FIGURE 2. Percentoftheadministereddosein repre
are data from the intestine (U), stomach (O), liv
Means are fromthree animals/time point ± SE.
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FIGURE 3. Thesensitivityofaccelerator mass spectrometry is limitedbythe
natural abundance of 14C in biological material as shown by [14C]2-
amino-3,8-dimethylimidazo[4,5-Jquinoxaline-DNA adduct data (6) mice
raisedonadietdepletedin"4C (U)showan80% reductionin 14C. This will
allow an additional 5-fold increase in the detection of macromolecular
damage. Alsoshownistheinstrumentbackgroundfor 14C. Dataarereported
as the ratioof"C atoms tototal carbon atoms isolated from the samples.
Methods
C57BL/6 male mice were obtained from Simonsen Lab-
oratory (Gilroy, CA) at 6-8 weeks of age and allowed to ac-
climatize for 1 week. Fordetermination ofthedistribution and
fate ofPhIP, the mice were administered [2-14CT-labeled PhIP
(50 mCi/mmole) by stomach intubation at a dose of41 ng/kg
bodyweight. Animals weresacrificed attime0, 0.5, 1, 3, 6, 12,
24, 48, and 96 hr following exposure, and tissues were im-
mediatelyremoved. Urinewascollected overiceatthe sametime
points andpooled with urine removed fromthebladder. Feces
were likewise collected and homogenized in water/methanol
(1:1). Allsamples werestoredat-20°Cuntil use. Threeindepen-
dent replications ofthe experiment were carried out. Sample
preparation for AMS and 14C determinations were carried out
using ourpreviously described methods (7,8).
-24t 48 72For assessing PhIP DNA adduct dosimetric relationships,
24 48 n PhIP was administered to(6-8-week-old C57BL/6malemiceby
gavage at doses of0, 1.0, 10.0, and 20.0 mg/kg. Tissues were
sentative tissues. Shown removed24hrlaterandstoredat-20°Cuntiluse. Inaddition, 2'-
er(nt, and kidney (shD). deoxyribobonucleoside-3 '-monophosphates were incubated
withN-hydroxy-PhIP inthe presenceofmousehepatic cytosol
asdescribed in Buonarati etal. (9). DNA from the tissues and
in vitro incubations were isolated and 32P-postlabeled as
describedpreviously (9).
assay forDNAadductdetectionthatincludeschromatographic
separationofspecificadductsandthusisquiteusefulforstudy-
ing mechanisms of adduct formason and repair. Here we
describethefateanddistributionof2-amino-1-methyl-6-phen-
ylimidazo[4,5-bipyridine (PhIP) at adoseequivalent tothe con-
sumptionof200 gcookedmeatand ontheformationofPhIPad-
ducts athigher doses.
Results
PhIP wasrapidly absorbed atthe41 ng/kgdoseandmaximal
bloodlevels werereachedwithin0.5 hr(Fig. 1). Excretion was
equally rapid. Ninety percent of the administered dose was
eliminated via the urine and 10% via the feces over the 96-hr
period. The systemic half-life ofthecompound was 1 hr.
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FIGURE 4. 32P-Pbstlabeling mapsfrommicegivenPhIPandin vitroreactionsofdeoxynucleosides with DNAbinding(PhlP) internmdiates. (A) Adduct mapsof
DNA isolated from representative mouse tissues24hrafterexposure to PhIP. DNA from anunexposed animal isshown forreference. Three PhIP-related ad-
duct spots arepresent intheliver, whereasonlytmo PhIP-relatedadduct spotsarepresentinothertissues. Thesecorrespondtoliveradductslabeled I and3. (B)
Adduct maps from a separate experiment showing DNA adducts formed from incubations of reactive PhIP intermediates with the 2'-deoxynucleotide
monophosphates. PhIPcanbe seentobindonly todeoxyguanosine-3'-monophosphate. Theseadduct spotsco-migratewithadductsisolated frommousetissues.
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FIGURE 5. DNA adduct levels in representative tissues ofthe mouse 24 hr
after administration of PhIP. Adduct levels were determined by 32p_
postlabeling. Means ofthree animals/dose ± SE.
Maximal concentrations ofPhIP were attained in the tissues
between 0.5 and 3 hr after exposure, shown in Figure 2. The
highesttissue levels ofPhIP or itsmetabolites werefound inthe
stomach and intestine, followed by the liver, kidney, and pan-
creas. SomeofthePhIP Ibundassociated withthestomach may
havebeendue toadsorptionoftheunabsorbed compoundfrom
the lumen surface ofthetissue. PhIPlevels in thetissues 96 hr
after exposure were 0.5-2% of the administered dose. The
residual levelsofPhIPinthetissues wereduepossibly tocovalent
binding ofactive metabolites to DNA and protein and are cur-
rently under study.
Sensitivity ofAMS
Theabsolutesensitivitylimitforbiological specimens is im-
posed by the natural 14C abundance present in all biological
material (Fig. 3). Theabsolutedetectionlimitoftheinstrument
for 14Cis 1 part14C/1015totalcarbon. Thenaturalabundanceof
14C inbiologicalmatteris 1 part 14C/1012totalcarbon, which is
twoordersofmagnitudeabovewhatcanberoutinelymeasured
by AMS. Inaneffort to furtherincrease ourability to measure
macromolecular damage at low dose, we have attempted to
reducetheamountof14Cpresentnaturallyinouranimalmodels.
Mice fed on a diet containing yeast protein obtained from
organisms grownonpetroleum-derived methanolhave20% of
the 14Cpresentincontemporarybiological matter. Thisdecrease
hasbeenachievedwithinonegeneration offeedingthe special
diet and will result in a 5-fold increase in the sensitivity of
biological AMS measurements. Low-dose DNA binding
analysis withheterocyclic amines is currently underway using
these animals.
PhIPAdduct Levels
PhIP-DNAadductlevelshavebeenmeasuredinthemouseby
32P-postabeling. Threeadductspotsareevidentinlivertissueat
all doses tested, and two adduct spots were found in all other
tissues(Fig.4A). ThestructuralnatureofthesePhIPadductsis
as yet undetermined. Incubation ofreactive PhIP metabolites
with 2'-deoxynucleotide-3'-monophosphates indicate that all
threeadductspotsarederivedfromdeoxyguanosine (Fig. 4B).
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Thedeoxyguanosineadductsco-chromatograph withtheadduct
spots formedin vivo. Interestingly, high levelsofDNAbinding
were detected in the pancreas, heart, and liver, which are not
target tissues forcarcinogenesis with this compound (2), (Fig.
5) DNA adducts for all tissues increased linearly with dose
within the dose range tested here. Lower doses are now being
assessed by AMS.
Conclusion
Determining the relationships between exposure, time,
systemic dose, anddose totargettissues iscriticalforascertain-
ingthevalidityofbiologicalmarkers. Herewehaveshownthat
thedietary carcinogen PhlP, atadoseequivalenttoconsumption
of200 g ofcooked beef, is quickly absorbed and distributed to
thetissues. Elimination isalsoveryrapid. DNAadductsarepre-
sent inmanytissues andincreaseasalinearfunctionofdose. Ad-
duct formation at higherdoses does not seem to correlate with
targettissuesforcarcinogenesis, suggestingthatadductforma-
tion alone is not necessarily indicative oftumorigenicity. The
linearity of the adduct dose-response curve reported here for
PhIP and also earlier for 2-amino-3,8-dimethylimidazo[4,5-
JAquinoxaline(6) suggeststhatnooravery lowthresholdexists
for DNA damage and that DNA adduct levels areindicative of
exposure. The levels atwhich DNA damage andthat DNA ad-
duct levels are indictive ofexposure. The levels atwhich DNA
damage translates into asignificantbiological effectneed tobe
determined beforeadducts canbevalidatedasmarkers foreffect
orrisk. Furtherstudies are inprocesstodefinetherelationship
between exposure, macromolecular damage, andbiological ef-
fect at low doses.
This manuscriptwaspresentedasaposterattheConference onBiomonitor-
ing and Susceptibility Markers in Human Cancer: Applications in Molecular
Epidemiology and Risk Assessment that was held in Kailua-Kona, Hawaii, 26
October-I November 1991.
Workperformed undertheauspices oftheU.S. Department ofEnergy by the
Lawrence Livermore National Laboratory (W-7405-ENG-4S).
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